110 related articles for article (PubMed ID: 21498700)
1. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
Krasagakis K; Metaxari M; Zervou M; Stathopoulos EN; Eberle J; Kanitakis J; Georgoulias V; Krüger-Krasagakis S; Tavernarakis N; Tosca AD
Anticancer Res; 2011 Mar; 31(3):807-11. PubMed ID: 21498700
[TBL] [Abstract][Full Text] [Related]
2. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL; Srikantha R; Messingham KN
J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
[TBL] [Abstract][Full Text] [Related]
3. Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
Waltari M; Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Int J Cancer; 2011 Aug; 129(3):619-28. PubMed ID: 20949558
[TBL] [Abstract][Full Text] [Related]
4. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
7. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis.
Kartha RV; Sundram UN
Mod Pathol; 2008 Feb; 21(2):96-104. PubMed ID: 18084259
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of Merkel cell carcinoma.
Houben R; Schrama D; Becker JC
Exp Dermatol; 2009 Mar; 18(3):193-8. PubMed ID: 19400830
[TBL] [Abstract][Full Text] [Related]
9. Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma.
Van Gele M; Boyle GM; Cook AL; Vandesompele J; Boonefaes T; Rottiers P; Van Roy N; De Paepe A; Parsons PG; Leonard JH; Speleman F
Oncogene; 2004 Apr; 23(15):2732-42. PubMed ID: 14755241
[TBL] [Abstract][Full Text] [Related]
10. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene.
Kassem A; Schöpflin A; Diaz C; Weyers W; Stickeler E; Werner M; Zur Hausen A
Cancer Res; 2008 Jul; 68(13):5009-13. PubMed ID: 18593898
[TBL] [Abstract][Full Text] [Related]
11. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
12. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
13. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors.
Lasota J; Miettinen M
Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma. Pathological and molecular aspects of diagnosis and clinical features.
Majewska H; Biernat W
Pol J Pathol; 2010; 61(3):117-23. PubMed ID: 21225493
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
[TBL] [Abstract][Full Text] [Related]
16. T1796A BRAF mutation is absent in Merkel cell carcinoma.
Worda M; Sreevidya CS; Ananthaswamy HN; Cerroni L; Kerl H; Wolf P
Br J Dermatol; 2005 Jul; 153(1):229-32. PubMed ID: 16029370
[No Abstract] [Full Text] [Related]
17. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.
Shuda M; Feng H; Kwun HJ; Rosen ST; Gjoerup O; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16272-7. PubMed ID: 18812503
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population.
Grabellus F; Worm K; Sheu SY; Siffert W; Schmid KW; Bachmann HS
J Clin Pathol; 2011 Nov; 64(11):1021-4. PubMed ID: 21757432
[TBL] [Abstract][Full Text] [Related]
19. Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
Hafner C; Houben R; Baeurle A; Ritter C; Schrama D; Landthaler M; Becker JC
PLoS One; 2012; 7(2):e31255. PubMed ID: 22363598
[TBL] [Abstract][Full Text] [Related]
20. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours.
Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M
Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]